NENC Medicines Subcommittee and NTAG decisions NICE TA916 – October 2023

The decision made with regard to NICE 30 day TA916 for Bimekizumab for treating active psoriatic arthritis can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/